Orchestra Biomed Holdings, Inc. (OBIO)
5.59
+0.12
(+2.19%)
USD |
NASDAQ |
Oct 23, 11:12
Orchestra Biomed Holdings Gross Profit Margin (Quarterly) : -37.50% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -37.50% |
| March 31, 2026 | 16.36% |
| December 31, 2025 | 99.70% |
| September 30, 2025 | 84.90% |
| June 30, 2025 | 84.81% |
| March 31, 2025 | 85.37% |
| December 31, 2024 | 60.47% |
| September 30, 2024 | 85.41% |
| June 30, 2024 | 84.83% |
| Date | Value |
|---|---|
| March 31, 2024 | 82.58% |
| December 31, 2023 | 68.32% |
| September 30, 2023 | 81.74% |
| June 30, 2023 | 68.85% |
| March 31, 2023 | 76.80% |
| December 31, 2022 | 92.02% |
| September 30, 2022 | 95.18% |
| June 30, 2022 | 38.40% |
| March 31, 2022 | 74.36% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Accuray, Inc. | 34.76% |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 69.55% |
| ResMed, Inc. | 58.12% |
| Rockwell Medical, Inc. | 18.24% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -157.2% |
| Return on Assets | -61.64% |
| Return on Invested Capital | -79.09% |
| Profit Margin (Quarterly) | -26.99K% |
| Operating Margin (Quarterly) | -25.40K% |
| Return on Net Operating Assets | -1.66K% |